NIH Trial Investigating Hydroxychloroquine Plus Azithromycin for COVID-19 Begins

COVID-19: NIH Trial of Hydroxychloroquine, Azithromycin; Zinc Add-On Investigated

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

2:58 AM (16 hours ago)

to me

If you are having trouble viewing this email, click here.

MUST READS NIH Trial Investigating Hydroxychloroquine Plus Azithromycin for COVID-19 Begins Addition of Zinc May Benefit Some Being Treated for COVID-19 Recall: Undeclared Antihypertensive Found in Compounded Hair Loss Drug Dasotraline Development for ADHD, Binge Eating Disorder Halted, NDAs Withdrawn Elafibranor Effect Not Significantly Different From Placebo in NASH Study MPR Weekly Dose Podcast MPR Weekly Dose Podcast Episode 34 COVID-19 Resource Center CME/CE Spotlight Dispelling the Myths of Influenza Management AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME